Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer

Takuya Shintani(Osaka University), Yasushi Fujio(Osaka University of Pharmaceutical Sciences)
Oncotarget
December 25, 2018
Cited by 10


Related Papers